Secretogranin II (SCG2) has been confirmed to be related to primitive neuroectodermal tumors of the brain, while secretogranin V (SCG5) primarily regulates the secretion of pituitary hormones, preventing the aggregation of secretion proteins linked to certain diseases. The gene discussed is SCG5; the disease is intracranial primitive neuroectodermal tumor.